Ruifa Han
- Urology top 5%
- Cancer Research top 10%
- Cancer, Hypoxia, and Metabolism 6
- Surgery top 10%
- Bladder and Urothelial Cancer Treatments 15
- Urinary and Genital Oncology Studies 5
-
- Epigenetics and DNA Methylation 8
- Angiogenesis and VEGF in Cancer 4
-
- Immune cells in cancer 7
- Immune Cell Function and Interaction 4
-
- Cancer Research and Treatments 4
- Cited by
- UrologyCancer ResearchSurgery
- Partner nations
- ChinaUnited StatesFinland
In The Last Decade
Ruifa Han
68 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 106
- Urology 88
- Cancer Research 171
- Surgery 350
- Molecular Biology 469
- Developmental Neuroscience 28
Countries citing papers authored by Ruifa Han
This map shows the geographic impact of Ruifa Han's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruifa Han with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruifa Han more than expected).
Fields of papers citing papers by Ruifa Han
This network shows the impact of papers produced by Ruifa Han. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruifa Han. The network helps show where Ruifa Han may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ruifa Han, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 7 | |
| 2 | The Importance of Socio-Psychological Factors and Lifestyle in ShapingHealth and Life Expectancy among Longlivers from PrecarpathianRegion (West Ukraine) | 2020 | 0 |
| 3 | MicroRNA-34a suppresses aggressiveness of hepatocellular carcinoma by modulating E2F1, E2F3, and Caspase-3 | 2019 | 6 |
| 4 | Analysis Of Re-Hospitalizations For Patients With Heart Failure Caused By Coronary Heart Disease: Data Of First Event And Recurrent Event | 2019 | 0 |
| 5 | 2017 | 9 | |
| 6 | 2016 | 5 | |
| 7 | 2015 | 36 | |
| 8 | 2015 | 5 | |
| 9 | 2014 | 6 | |
| 10 | 2013 | 7 | |
| 11 | 2013 | 4 | |
| 12 | 2010 | 25 | |
| 13 | 2010 | 98 | |
| 14 | Expression and significance of endostatin,VEGF and MVD in renal cell carcinoma | 2009 | 1 |
| 15 | 2009 | 18 | |
| 16 | 2009 | 25 | |
| 17 | 2008 | 68 | |
| 18 | The Study on the Method of Predicting Renal Function Recoverability of Obstructed Renal Failure with Resistive Index by Two-dimensional Ultrasound | 2008 | 0 |
| 19 | 2008 | 39 | |
| 20 | 2007 | 11 |
About Ruifa Han
Ruifa Han is a scholar working on Cancer Research, Immunology, Molecular Biology, Internal Medicine and Developmental Neuroscience, having authored 72 papers that have together received 1.1k indexed citations. Recurring topics across this work include Bladder and Urothelial Cancer Treatments (15 papers), Epigenetics and DNA Methylation (8 papers), Immune cells in cancer (7 papers), Cancer, Hypoxia, and Metabolism (6 papers), Urinary and Genital Oncology Studies (5 papers), Cancer Research and Treatments (4 papers), Immune Cell Function and Interaction (4 papers) and Angiogenesis and VEGF in Cancer (4 papers). The work is most often cited by research in Urology (88 citations), Cancer Research (171 citations), Surgery (350 citations), Molecular Biology (469 citations) and Developmental Neuroscience (28 citations). Ruifa Han has collaborated with scholars based in China, United States and Finland. Frequent co-authors include Weiyang Tao, Hongchi Jiang, Qi-Yin Chen, Shaobin Ni, Chunyang Wang, Hailong Hu, Yan Sun, Lianxin Liu, Yuanjie Niu and Liwei Liu. Their work appears in journals such as Urology, OncoTargets and Therapy, European Urology, Cancer Research and Oncology Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.